BioCentury
ARTICLE | Company News

Biovail gets generic approval

March 13, 2000 8:00 AM UTC

Biovail (BVF; TSE:BVF) received FDA marketing approval for its 30 mg generic Adalat nifedipine to treat hypertension. The product, in-licensed from Elan (ELN) in October 1999, will be marketed in the ...